HUMAN-COMPUTER INTERACTIVE DEVICE AND METHOD

    公开(公告)号:US20250000447A1

    公开(公告)日:2025-01-02

    申请号:US18779075

    申请日:2024-07-21

    Applicant: Cheng QIAN

    Inventor: Cheng QIAN

    Abstract: The present disclosure relates to a bioelectrical signal acquisition device, an interactive system, and related methods. The bioelectrical signal acquisition device includes a series of electrodes that are configured and positioned to effectively record bioelectrical signals from a user's head. The interactive system and related methods can be used to collect, display, and analyze the bioelectrical signals, especially signals related to sleep. The device, system, and methods can also be applied to modulate physiological or pathological conditions of the user.

    Displaying cellular analysis result data using a template
    2.
    发明授权
    Displaying cellular analysis result data using a template 有权
    使用模板显示细胞分析结果数据

    公开(公告)号:US08217943B2

    公开(公告)日:2012-07-10

    申请号:US11408455

    申请日:2006-04-21

    Abstract: In accordance with the principles of the invention, methods, systems, and computer-readable mediums are provided for displaying cellular analysis result data including accessing cellular analysis result data, accessing data of at least one template, and displaying the cellular analysis result data and the data of at least one template by overlaying the cellular analysis result data and the data of the at least one template, wherein the cellular analysis result data is displayed using different display attributes from the displayed data of the at least one template.

    Abstract translation: 根据本发明的原理,提供了方法,系统和计算机可读介质,用于显示细胞分析结果数据,包括访问细胞分析结果数据,访问至少一个模板的数据,以及显示细胞分析结果数据和 通过覆盖所述细胞分析结果数据和所述至少一个模板的数据来至少一个模板的数据,其中使用与所述至少一个模板的所显示的数据不同的显示属性来显示所述细胞分析结果数据。

    Voltage regulator module control circuit
    3.
    发明授权
    Voltage regulator module control circuit 失效
    电压调节器模块控制电路

    公开(公告)号:US07751158B2

    公开(公告)日:2010-07-06

    申请号:US11960753

    申请日:2007-12-20

    CPC classification number: H02M3/1584 H02M1/32

    Abstract: An exemplary voltage regulator module (VRM) control circuit includes a VRM providing a plurality of phases, each of the phases connected to a control terminal of a corresponding electric switch; a comparator comprising a non-inverting terminal connected to a first power source and grounded via the electric switches respectively, an inverting terminal connected to a reference voltage, and an output terminal; and a control switch connected between an enable terminal of the VRM and ground, the control switch comprising a control terminal connected to the output terminal of the comparator, wherein, if one of the phases of the VRM is lost, the corresponding electric switch is turned off, and a voltage of the non-inverting terminal of the comparator is higher than the reference voltage, the comparator outputs a control signal to the control switch for turning on the control switch, thus turning off the VRM.

    Abstract translation: 示例性的电压调节器模块(VRM)控制电路包括提供多个相位的VRM,每个相位连接到相应的电开关的控制端; 比较器,其包括连接到第一电源并且经由电开关分别接地的同相端子,连接到参考电压的反相端子和输出端子; 以及控制开关,其连接在所述VRM的使能端子和地之间,所述控制开关包括连接到所述比较器的输出端子的控制端子,其中,如果所述VRM的所述相位之一丢失,则相应的电开关被转动 关断,并且比较器的同相端子的电压高于参考电压,比较器向控制开关输出控制信号以接通控制开关,从而关闭VRM。

    VOLTAGE DETECTION DEVICE
    4.
    发明申请
    VOLTAGE DETECTION DEVICE 失效
    电压检测装置

    公开(公告)号:US20090313494A1

    公开(公告)日:2009-12-17

    申请号:US12195447

    申请日:2008-08-21

    CPC classification number: G06F1/26

    Abstract: An voltage detection device includes a comparator circuit comprising a first input terminal connected to a system power supply, a second input terminal connected to a standby power supply, an output terminal capable of outputting a control voltage according to comparison result; an indicator circuit; and a switch circuit connected between the standby power supply and the indicator circuit, comprising a control terminal to receive the control voltage from the comparator circuit thereby to control the standby power supply supplied to the indicator circuit or not; a power state terminal of the computer connected to a node between the standby power supply and the indicator circuit, wherein the power state terminal is at a low level when the computer is turned off. The voltage detection device can ensure that all the power supplies provide power to the computer components normally.

    Abstract translation: 电压检测装置包括:比较电路,包括连接到系统电源的第一输入端子,连接到备用电源的第二输入端子,能够根据比较结果输出控制电压的输出端子; 指示电路; 以及连接在备用电源和指示器电路之间的开关电路,包括控制端子,用于从比较器电路接收控制电压,从而控制提供给指示器电路的备用电源; 连接到备用电源和指示器电路之间的节点的计算机的电源状态终端,其中当计算机关闭时,电源状态终端处于低电平。 电压检测装置可以确保所有电源正常地为计算机组件供电。

    FUNCTIONALIZED FEW-WALLED CARBON NANOTUBES (FWNTs) AND METHODS OF MAKING AND USING THE SAME
    5.
    发明申请
    FUNCTIONALIZED FEW-WALLED CARBON NANOTUBES (FWNTs) AND METHODS OF MAKING AND USING THE SAME 审中-公开
    功能性金属微球碳纳米管(FWNT)及其制造方法和使用方法

    公开(公告)号:US20080260617A1

    公开(公告)日:2008-10-23

    申请号:US11934727

    申请日:2007-11-02

    CPC classification number: B82Y40/00 B82Y30/00 C01B32/162 C01B32/17 C01B2202/04

    Abstract: Few-walled carbon nanotubes (FWNTs) can be synthesized in a simple chemical vapor deposition (CVD) system using a mixture of methanol and ethanol as the carbon source. In preferred embodiments, the present invention uses an ethanol/methanol mixture as the carbon source so that few walled nanotubes (FWNTs) with high purity can be prepared following a simplified purification process. Under the growth conditions of the present invention, ethanol is believed to act as the carbon source while methanol is believed to act as a “carbonaceous impurity remover” to remove the impurities deposited on a support (e.g., MgO) and thereby hinder the formation of such impurities.

    Abstract translation: 可以在使用甲醇和乙醇作为碳源的混合物的简单化学气相沉积(CVD)系统中合成少量壁碳纳米管(FWNT)。 在优选的实施方案中,本发明使用乙醇/甲醇混合物作为碳源,使得可以在简化的纯化方法之后制备出很少的具有高纯度的壁纳米管(FWNT)。 在本发明的生长条件下,认为乙醇作为碳源,而甲醇据信作为“含碳杂质去除剂”去除沉积在载体(例如MgO)上的杂质,从而阻碍了形成 这样的杂质。

    Adenovirus/Alphavirus Hybrid Vector for the Effective Administration and Expression of Therapeutic Genes in Tumour Cells
    6.
    发明申请
    Adenovirus/Alphavirus Hybrid Vector for the Effective Administration and Expression of Therapeutic Genes in Tumour Cells 失效
    用于有效施用和表达肿瘤细胞中治疗基因的腺病毒/甲病毒属混合载体

    公开(公告)号:US20070224170A1

    公开(公告)日:2007-09-27

    申请号:US11569303

    申请日:2005-05-18

    Abstract: The present invention relates to a genic expression adenoviral hybrid vector characterized in that it contains at least the following elements, oriented in the direction 5′ to 3′: i. a first chain of adenoviral origin comprising a first inverted terminal repeat (ITR) sequence and a signal sequence for packaging of the adenovirus; ii. a first non-encoding stuffer sequence; iii. a sequence corresponding to a tissue specific promoter; iv. a chain of cDNA derived from an alphavirus, the sequence of which is partly complementary to an alphaviral RNA sequence, comprising at least a sequence encoding for at least one exogenous gene of interest; v. a polyadenylation sequence; and vi. a second adenoviral inverted terminal repeat (ITR) sequence, it preferably relates to an adenoviral hybrid vector comprising as exogenous gene of interest the therapeutic gene of mammalian interleukin IL-12 and even more preferably human interleukin hIL-12; and to the use of the hybrid vector in a process for transferring genetic material to a cell, particularly a tumor cell that preferably expresses alpha-fetoprotein (AFP), and to its use for inducing an immune response against foreign antigens.

    Abstract translation: 本发明涉及一种基因表达腺病毒杂合载体,其特征在于其至少包含以5'至3'方向取向的以下元件:i。 包括第一反向末端重复序列(ITR)序列和用于包装腺病毒的信号序列的第一个腺病毒源, ii。 第一个非编码填充序列; iii。 对应于组织特异性启动子的序列; iv。 源自甲病毒病毒的cDNA链,其序列与甲病毒RNA序列部分互补,包含至少一个编码至少一种感兴趣的外源基因的序列; v。多腺苷酸化序列; 和vi。 第二种腺病毒反向末端重复(ITR)序列,优选涉及包含作为感兴趣的外源基因的哺乳动物白介素IL-12的治疗基因,甚至更优选人白细胞介素hIL-12的腺病毒杂交载体; 以及将遗传物质转移到细胞,特别是优选表达甲胎蛋白(AFP)的肿瘤细胞的方法中以及其用于诱导针对外来抗原的免疫应答的用途的用途。

    Method of hemoglobin correction due to temperature variation
    8.
    发明申请
    Method of hemoglobin correction due to temperature variation 审中-公开
    由于温度变化引起的血红蛋白校正方法

    公开(公告)号:US20070054404A1

    公开(公告)日:2007-03-08

    申请号:US11222457

    申请日:2005-09-08

    CPC classification number: G01N33/721 G01N33/726

    Abstract: A method of measuring a hemoglobin parameter of a test sample of blood comprises diluting and lysing a test sample. Then, a temperature corresponding to the test sample is obtained. The diluted and lysed test sample is then delivered to a cuvette, and a spectrophotometer determines the absorbance and/or transmittance of the sample in the cuvette. With the absorbance and/or transmittance of the test sample, a first measurement of the hemoglobin parameter of the test sample is obtained. After a first measurement of the hemoglobin parameter is obtained, a processor determines a corrected measurement of the hemoglobin parameter of the test sample. The corrected measurement is a function of the measured temperature that corresponds to the test sample and the first measurement of the hemoglobin parameter. The method of measuring a hemoglobin parameter is valid over a range of test sample temperatures.

    Abstract translation: 测量血液的测试样品的血红蛋白参数的方法包括稀释和裂解测试样品。 然后,获得与测试样品相对应的温度。 稀释并裂解的测试样品然后输送到比色皿,分光光度计确定样品在比色杯中的吸光度和/或透射率。 利用测试样品的吸光度和/或透射率,获得测试样品的血红蛋白参数的第一次测量。 在获得血红蛋白参数的第一次测量之后,处理器确定测试样品的血红蛋白参数的校正测量值。 校正的测量值是对应于测试样品的测量温度和血红蛋白参数的第一次测量的函数。 测量血红蛋白参数的方法在测试样品温度范围内有效。

    Human-computer interactive device and method

    公开(公告)号:US12042296B2

    公开(公告)日:2024-07-23

    申请号:US17937187

    申请日:2022-09-30

    Applicant: Cheng Qian

    Inventor: Cheng Qian

    CPC classification number: A61B5/4806 A61B5/291 A61B5/374 A61B5/6803 A61B5/6814

    Abstract: The present disclosure relates to a bioelectrical signal acquisition device, an interactive system, and related methods. The bioelectrical signal acquisition device includes a series of electrodes that are configured and positioned to effectively record bioelectrical signals from a user's head. The interactive system and related methods can be used to collect, display, and analyze the bioelectrical signals, especially signals related to sleep. The device, system, and methods can also be applied to modulate physiological or pathological conditions of the user.

Patent Agency Ranking